JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 48:2584-2591, doi:10.1016/j.jacc.2006.10.026 (Published online 1 November 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.10.026v1
48/12/2584    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfisterer, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pfisterer, M.

EXPEDITED REVIEW

Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

An Observational Study of Drug-Eluting Versus Bare-Metal Stents

Matthias Pfisterer, MD, FACC*,*, Hans Peter Brunner-La Rocca, MD*, Peter T. Buser, MD, FACC*, Peter Rickenbacher, MD§, Patrick Hunziker, MD{dagger}, Christian Mueller, MD{ddagger}, Raban Jeger, MD*, Franziska Bader, RN*, Stefan Osswald, MD, FACC*, Christoph Kaiser, MD* for the BASKET-LATE Investigators

* Departments of Cardiology
{dagger} Intensive Care Medicine
{ddagger} Internal Medicine, University Hospital
§ Bruderholzspital, Basel, Switzerland

Manuscript received June 6, 2006; revised manuscript received August 24, 2006, accepted August 28, 2006.

* Reprint requests and correspondence: Dr. Matthias Pfisterer, Professor of Cardiology, Head Department of Cardiology, University Hospital, CH-4031 Basel, Switzerland (Email: pfisterer{at}email.ch).

OBJECTIVES: We sought to define the incidence of late clinical events and late stent thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after the discontinuation of clopidogrel as well as their timing and outcome.

BACKGROUND: There is growing concern that delayed endothelialization after DES implantation may lead to late stent thrombosis and related myocardial infarction (MI) or death. However, event rates and outcomes after clopidogrel discontinuation versus BMS are unknown.

METHODS: A consecutive series of 746 nonselected patients with 1,133 stented lesions surviving 6 months without major events were followed for 1 year after the discontinuation of clopidogrel. Patients were assigned randomly 2:1 to DES versus BMS in BASKET (Basel Stent Kosten Effektivitäts Trial). The primary focus of this observation was cardiac death/MI.

RESULTS: Rates of 18-month cardiac death/MI were not different between DES and BMS patients. However, after the discontinuation of clopidogrel (between months 7 and 18), these events occurred in 4.9% after DES versus 1.3% after BMS implantation. Target vessel revascularization remained lower after DES, resulting in similar rates of all clinical events for this time period (DES 9.3%, BMS 7.9%). Documented late stent thrombosis and related death/target vessel MI were twice as frequent after DES versus BMS (2.6% vs. 1.3%). Thrombosis-related events occurred between 15 and 362 days after the discontinuation of clopidogrel, presenting as MI or death in 88%.

CONCLUSIONS: After the discontinuation of clopidogrel, the benefit of DES in reducing target vessel revascularization is maintained but has to be balanced against an increase in late cardiac death or nonfatal MI, possibly related to late stent thrombosis.

Abbreviations and Acronyms
  BASKET = Basel Stent Kosten Effektivitäts Trial
  BASKET-LATE = BASKET LAte Thrombotic Events Trial
  BMS = bare-metal stent
  CI = confidence interval
  DES = drug-eluting stent
  HR = hazard ratio
  MI = myocardial infarction
  OR = odds ratio
  TVR = target vessel revascularization




This article has been cited by other articles:


Home page
 Eur Heart JHome page
S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin, et al.
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial
Eur. Heart J., July 1, 2008; 29(13): 1625 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. J. Malenka, A. V. Kaplan, F. L. Lucas, S. M. Sharp, and J. S. Skinner
Outcomes Following Coronary Stenting in the Era of Bare-Metal vs the Era of Drug-Eluting Stents
JAMA, June 25, 2008; 299(24): 2868 - 2876.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Alfonso
The "vulnerable" stent why so dreadful?
J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2403 - 2406.
[Full Text] [PDF]

Home page
 CirculationHome page
A. S. Brett
Coronary Assessment Before Noncardiac Surgery: Current Strategies Are Flawed
Circulation, June 17, 2008; 117(24): 3145 - 3151.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Roy, D. H. Steinberg, S. J. Sushinsky, T. Okabe, T. L. P. Slottow, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, et al.
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents
Eur. Heart J., June 11, 2008; (2008) ehn249v1.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. Meliga, H. M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A. O. Maree, S. Cook, L. Reardon, C. Moretti, S. De Servi, et al.
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2212 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. S. Brar, J. Kim, S. K. Brar, R. Zadegan, M. Ree, I.-L. A. Liu, P. Mansukhani, V. Aharonian, R. Hyett, and A. Y.-J. Shen
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2220 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S.-H. Choi, A. Prasad, and S. Tsimikas
The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2228 - 2229.
[Full Text] [PDF]

Home page
 J Public Health (Oxf)Home page
D. Austin, K. G. Oldroyd, A. McConnachie, R. Slack, H. Eteiba, A. D. Flapan, K. P. Jennings, R. J. Northcote, A. C. H. Pell, I. R. Starkey, et al.
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in Scotland
J. Public Health Med., June 1, 2008; 30(2): 186 - 193.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. C. Becker, T. W. Meade, P. B. Berger, M. Ezekowitz, C. M. O'Connor, D. A. Vorchheimer, G. H. Guyatt, D. B. Mark, and R. A. Harrington
The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 776S - 814S.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Kelbaek, L. Klovgaard, S. Helqvist, J. F. Lassen, L. R. Krusell, T. Engstrom, H. E. Botker, E. Jorgensen, K. Saunamaki, S. Aljabbari, et al.
Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions 3-Year Results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) Trial.
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2011 - 2016.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Garg, D. J. Cohen, T. Gaziano, and L. Mauri
Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents: Results of a Decision Analytic Model
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1844 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. B. Mark
Interpreting the Music of Drug-Eluting Stents: Halcyon Song or Albatross Dirge?
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1854 - 1856.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. H Bhatt and T. H Hauser
Very Late Stent Thrombosis After Dual Antiplatelet Therapy Discontinuation in a Patient with a History of Acute Stent Thrombosis
Ann. Pharmacother., May 1, 2008; 42(5): 708 - 712.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
S. R. Mulukutla, H. A. Vlachos, O. C. Marroquin, F. Selzer, E. M. Holper, J. D. Abbott, W. K. Laskey, D. O. Williams, C. Smith, W. D. Anderson, et al.
Impact of Drug-Eluting Stents Among Insulin-Treated Diabetic Patients: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 139 - 147.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
B. L. van der Hoeven, S.-S. Liem, J. Dijkstra, S. C. Bergheanu, H. Putter, M. L. Antoni, D. E. Atsma, M. Bootsma, K. Zeppenfeld, J. W. Jukema, et al.
Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 192 - 201.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. J. Zellweger, C. Kaiser, H. P. Brunner-La Rocca, P. T. Buser, S. Osswald, P. Weiss, J. Mueller-Brand, M. E. Pfisterer, and for the BASKET Investigators
Value and Limitations of Target-Vessel Ischemia in Predicting Late Clinical Events After Drug-Eluting Stent Implantation
J. Nucl. Med., April 1, 2008; 49(4): 550 - 556.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
K. T Reaume, R. E Regal, and M. P Dorsch
Indications for Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Evidence-Based Recommendations for Use
Ann. Pharmacother., April 1, 2008; 42(4): 550 - 557.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Kelbaek, C. J. Terkelsen, S. Helqvist, J. F. Lassen, P. Clemmensen, L. Klovgaard, A. Kaltoft, T. Engstrom, H. E. Botker, K. Saunamaki, et al.
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 899 - 905.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Pfisterer, H. P. Brunner-La Rocca, and C. Kaiser
The balance of risks and benefits of drug-eluting versus bare-metal stents.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 972 - 972.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Thuesen, L. O. Jensen, A. Kaltoft, and M. Maeng
Reply.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 972 - 973.
[Full Text] [PDF]

Home page
 HeartHome page
R Hoffmann, M-C Morice, J W Moses, P J Fitzgerald, L Mauri, G Breithardt, J Schofer, P W Serruys, H-P Stoll, and M B Leon
Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials
Heart, March 1, 2008; 94(3): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Francescone and J. L. Halperin
"Triple Therapy" or Triple Threat?: Balancing the Risks of Antithrombotic Therapy for Patients With Atrial Fibrillation and Coronary Stents
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 826 - 827.
[Full Text] [PDF]

Home page
 CirculationHome page
P. Ortolani, M. Balducelli, P. Marzaroli, G. Piovaccari, A. Menozzi, V. Guiducci, P. Sangiorgio, F. Tarantino, G. Geraci, F. Castriota, et al.
Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry
Circulation, February 19, 2008; 117(7): 923 - 930.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. Applegate, M. T. Sacrinty, M. A. Kutcher, R. M. Santos, S. K. Gandhi, T. T. Baki, and W. C. Little
"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 607 - 614.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. Jeremias and A. Kirtane
Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
Ann Intern Med, February 5, 2008; 148(3): 234 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Cardiovascular DiseaseHome page
F. Saia, A. Marzocchi, and A. Branzi
Review: The safety of drug-eluting stents
Therapeutic Advances in Cardiovascular Disease, February 1, 2008; 2(1): 43 - 52.
[Abstract] [PDF]

Home page
 HeartHome page
D. Austin, J. P Pell, and K. G Oldroyd
Drug-eluting stents: do the risks really outweigh the benefits?
Heart, February 1, 2008; 94(2): 127 - 128.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo
Drug-Eluting Stenting: The Case for Post-Dilation
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. P. Carrozza Jr.
Drug-Eluting Stents -- Pushing the Envelope beyond the Labels?
N. Engl. J. Med., January 24, 2008; 358(4): 405 - 407.
[Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
D. Sutphin, S. Stevens, D. Kirzeder, and J. Gash
Acute Thrombosis of a Mesenteric Artery Drug-Eluting Stent Following Clopidogrel Cessation
Vascular and Endovascular Surgery, January 1, 2008; 41(6): 564 - 567.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
T. D. Fraker Jr, S. D. Fihn, and Writing on behalf of the 2002 Chronic Stable Angin
2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2264 - 2274.
[Full Text] [PDF]

Home page
 CirculationHome page
T. D. Fraker Jr, S. D. Fihn, Writing on behalf of the 2002 Chronic Stable Angin, 2002 WRITING COMMITTEE MEMBERS, R. J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P. C. Deedwania, J. S. Douglas, et al.
2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina
Circulation, December 4, 2007; 116(23): 2762 - 2772.
[Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
S. Singh, R. Arora, A. Khraisat, K. Handa, A. Bahekar, A. Trivedi, and S. Khosla
Increased Incidence of In-Stent Thrombosis Related to Cocaine Use: Case Series and Review of Literature
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 298 - 303.
[Abstract] [PDF]

Home page
 ICVTSHome page
F. Unger
Drug eluting stents a nightmare?
Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 813 - 814.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M. Takano, M. Yamamoto, Y. Xie, D. Murakami, S. Inami, K. Okamatsu, K. Seimiya, T. Ohba, Y. Seino, and K. Mizuno
Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy
Heart, December 1, 2007; 93(12): 1533 - 1536.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. V. Finn, M. C. John, H. K. Gold, J. Newell, G. Nakazawa, M. Joner, F. D. Kolodgie, and R. Virmani
Response to Letter Regarding Article, "Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization"
Circulation, November 27, 2007; 116(22): e550 - e550.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. D. Abbott, M. R. Voss, M. Nakamura, H. A. Cohen, F. Selzer, K. E. Kip, H. A. Vlachos, R. L. Wilensky, and D. O. Williams
Unrestricted Use of Drug-Eluting Stents Compared With Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood Institute Dynamic Registry
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2029 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. Doyle, C. S. Rihal, C. J. O'Sullivan, R. J. Lennon, H. J. Wiste, M. Bell, J. Bresnahan, and D. R. Holmes Jr
Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents
Circulation, November 20, 2007; 116(21): 2391 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M. Takano, M. Yamamoto, Y. Xie, D. Murakami, S. Inami, K. Okamatsu, K. Seimiya, T. Ohba, Y. Seino, and K. Mizuno
Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy
Heart, November 1, 2007; 93(11): 1353 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation, October 23, 2007; 116(17): 1952 - 1965.
[Full Text] [PDF]

Home page
 CirculationHome page
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Circulation, October 23, 2007; 116(17): e418 - e499.
[Full Text] [PDF]

Home page
 NEJMHome page
J. V. Tu, J. Bowen, M. Chiu, D. T. Ko, P. C. Austin, Y. He, R. Hopkins, J.-E. Tarride, G. Blackhouse, C. Lazzam, et al.
Effectiveness and Safety of Drug-Eluting Stents in Ontario
N. Engl. J. Med., October 4, 2007; 357(14): 1393 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Schomig, A. Dibra, S. Windecker, J. Mehilli, J. Suarez de Lezo, C. Kaiser, S.-J. Park, J.-J. Goy, J.-H. Lee, E. Di Lorenzo, et al.
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1373 - 1380.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. E. Rodriguez, A. O. Maree, J. Mieres, D. Berrocal, L. Grinfeld, C. Fernandez-Pereira, V. Curotto, A. Rodriguez-Granillo, W. O'Neill, and I. F. Palacios
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry
Eur. Heart J., September 1, 2007; 28(17): 2118 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726.
[Full Text] [PDF]

Home page
 CirculationHome page
F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, C. Godino, et al.
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment
Circulation, August 14, 2007; 116(7): 745 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. A. Lin, R. A. Dudley, and R. F. Redberg
Cardiologists' Use of Percutaneous Coronary Interventions for Stable Coronary Artery Disease
Arch Intern Med, August 13, 2007; 167(15): 1604 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Machecourt, N. Danchin, J. M. Lablanche, J. M. Fauvel, J. L. Bonnet, S. Marliere, A. Foote, J. L. Quesada, H. Eltchaninoff, G. Vanzetto, et al.
Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients: The EVASTENT Matched-Cohort Registry
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 501 - 508.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. L. Frye
Update in Cardiology
Ann Intern Med, August 7, 2007; 147(3): 180 - 186.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
C. Bode and M. Zehender
The use of antiplatelet agents following percutaneous coronary intervention: focus on late stent thrombosis
Eur. Heart J. Suppl., August 1, 2007; 9(suppl_D): D10 - D19.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Fiorella and H. H. Woo
Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease
Stroke, August 1, 2007; 38(8): 2391 - 2396.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. O. Jensen, M. Maeng, A. Kaltoft, P. Thayssen, H. H. T. Hansen, M. Bottcher, J. F. Lassen, L. R. Krussel, K. Rasmussen, K. N. Hansen, et al.
Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions
J. Am. Coll. Cardiol., July 31, 2007; 50(5): 463 - 470.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Vermeersch, P. Agostoni, S. Verheye, P. Van den Heuvel, C. Convens, F. Van den Branden, G. Van Langenhove, and DELAYED RRISC (Death and Events at Long-term follo
Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results From the Randomized DELAYED RRISC Trial
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 261 - 267.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. G. Ellis
"Crying Fire in a Theater" or a "Confirmatory Sighting?"
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 268 - 269.
[Full Text] [PDF]